2006-12-14 - Male - 24 Years old
210715
| Adverse reaction report number | 210715 |
| Latest AER version number | 0 |
| Market authorization holder AER number | SPV1200601964 |
| Initial received date | 2006-12-14 |
| Latest received date | 2007-01-08 |
| Age | 24 Years |
| Gender | Male |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Physician |
| Source of report | MAH |
| Report outcome | Not recovered/not resolved |
| Serious report? | Yes |
Reason for seriousness
| Death | |
| Disability | |
| Cogenital anomaly | |
| Life threateting | |
| Hospitalization | |
| Other medically important | Yes |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 15 Milligram | 1 every 1 Day(s) | 30 Day(s) | |
| CORTICOSTEROID(S) | NOT SPECIFIED | Concomitant | Inhalation | ||||
| VENTOLIN FOR INHALATION | NOT SPECIFIED | Concomitant | Inhalation | ||||
| VERAPAMIL HYDROCHLORIDE INJECTION USP | LIQUID INTRAVENOUS | Drug used to treat AE | Unknown |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Supraventricular tachycardia | |